Back to MW MARSHALL WACE, LLP

SMTISMTI
9 quarters

Position history for MWMARSHALL WACE, LLP's holdings in SANARA MEDTECH INC

Yes. Marshall Wace holds 49,457 shares of SMTI (Sanara Medtech), worth $1.2M, as of its Q2 2026 13F filing. It reduced the position by 26,825 shares (-35.2%) from Q1 2026. Marshall Wace has held SMTI since Q4 2024, across 7 quarterly 13F filings.

Current Value

$1.2M

Current Shares

49,457

Total Value Change

+$932,827

Total Shares Change

+43,625

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
49,457
-35.2%
$1.2M0.0%$23.59
0
2026-Q1
Increased
76,282
+56.9%
$1.3M0.0%$17.18
36
2025-Q4
Decreased
48,611
-26.4%
$1.1M0.0%$23.35
0
2025-Q3
Decreased
66,073
-7.6%
$2.1M0.0%$31.73
0
2025-Q2
Increased
71,511
+144.3%
$2M0.0%$28.39
42
2025-Q1
Decreased
29,274
-3.3%
$903,6880.0%$30.87
0
2024-Q4
New
30,285
-
$1M0.0%$33.20
35
2023-Q3
Exited
0
-100.0%
$00.0%$31.13
0
2023-Q2
New
5,832
-
$233,8630.0%$40.10
32

Other major holders of SMTI: Baird Financial Group, Inc., BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used